PHA 955 SYSTEMS for CONTROLLED DRUG DELIVERY and DELIVERY MECHANISMS
Terminology, examination of the properties of active ingredient to be prepared controlled release form, examining the physicochemical properties of the active agent, the examination of biopharmaceutical-pharmacokinetic properties of the active substance, determining the controlled release dosage forms to be made , the oral controlled release forms, the matrix type preparations, capsules, osmotic pumps, floating dosage forms , bioadhesive systems, microparticle systems, dose design, other areas of application, transdermal systems, parenteral systems, the implanted system, ocular systems, rectal and vaginal systems, nasal and pulmonary systems, buccal systems, the selection of the type of polymer used, examination of the release mechanism, controlled release regulations relating to systems, applications in veterinary medicine, pesticide application areas.